Tenon Medical

Tenon Medical's mission is to optimize surgical solutions for sacroiliac (SI) joint disorders through its innovative Catamaran System. The company has achieved FDA clearance, initiated commercial launch, and generated compelling post-market clinical data demonstrating significant pain reduction, functional improvement, and a strong safety profile. Its strategy centers on surgeon training and market penetration to capture share in the growing SI joint fusion market, leveraging a differentiated implant design and surgical approach.

The Catamaran SI Joint Fusion System, comprising a single titanium implant with bone-graft-friendly pontoons and a transfixing osteotome, delivered via a proprietary inferior-posterior surgical approach designed for safety and fusion.

Tenon competes in the SI joint fusion market against established players like SI-BONE, Medtronic, and Globus Medical, who use lateral multi-implant approaches, and others using posterior techniques. Tenon differentiates with its single-implant, inferior-posterior approach designed for enhanced safety and true intra-articular fusion, but must overcome competitors' extensive clinical data and sales reach.